Patent · US Active

Determination of hepatitis C virus genotype

US8071750B2 · kind B2 · utility

1Cited by
30References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 30, 2008
Grant dateDec 6, 2011
Priority date
Expiry dateDec 30, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides compositions and methods for the detection and characterization of HCV sequences. More particularly, the present invention provides compositions, methods and kits for using invasive cleavage structure assays (e.g. the INVADER assay) to screen nucleic acid samples, e.g., from patients, to determine HCV genotype.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.